marijuana stocks

Insys Therapeutics misses 2Q profit forecasts

Insys Therapeutics posts 2Q profit of $7.3 million, result misses forecasts

 CHANDLER, Ariz. (AP) _ Insys Therapeutics Inc. (INSY) on Thursday reported second-quarter net income of $7.3 million.

The Chandler, Arizona-based company said it had net income of 10 cents per share. Earnings, adjusted for stock option expense and pretax expenses, came to 21 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.

The specialty pharmaceutical company posted revenue of $77.6 million in the period.

Insys Therapeutics shares have more than doubled since the beginning of the year. The stock has more than tripled in the last 12 months.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$TAUG Files Form 10-Q/A

Form 10-Q/A for TAURIGA SCIENCES, INC. 19-Dec-2014 Quarterly Report FACTORS” IN THIS…

Zoned Properties®, Inc. (ZDPY) Announces the Appointment of Jody Kane to the Board of Directors

Zoned Properties Announces the Appointment of Jody Kane to the Board of…

Village Farms International, Inc. (VFF) Comments on Canadian Budget

Village Farms International Comments on Canadian Budget Village Farms International, Inc. (“Village…

TILT Holdings Inc. (TLLTF) Announces Upcoming Conference Schedule

TILT Holdings Announces Upcoming Conference Schedule TILT Holdings Inc. (“TILT” or the…